Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse
AUTOR(ES)
Ema, Masatsugu
FONTE
Cold Spring Harbor Laboratory Press
RESUMO
Mouse embryos mutant for the VEGF receptor, VEGFR2, Flk-1, or Kdr, fail to form both endothelial and hematopoietic cells, suggesting a possible role in a common progenitor to both lineages. The transcription factor Tal1 (Scl), is not expressed in Flk1−/− embryos, consistent with a downstream role in the Flk1 pathway. We tested whether expression of Tal1 under the Flk1 promoter was sufficient to rescue the loss of endothelial and hematopoietic cells in Flk1 mutants. Only partial rescue of hematopoiesis and endothelial development was observed in vivo. However, Flk1−/Tal1 embryonic stem (ES) cells were capable of blast colony formation in vitro at levels equivalent to Flk1+/− heterozygotes. Ectopic expression of Tal1 under the Flk1 promoter in Flk1+/− mouse embryos or ES cells caused no obvious pathology but increased the number of blast colony forming cells (BL-CFCs) and enhanced their hematopoietic potential. These single-cell-derived BL-CFCs also produced smooth muscle cells in vitro. Increased Tal1 expression inhibited smooth muscle differentiation in this assay, whereas loss of Tal1 promoted smooth muscle formation. We propose a model in which the combinatorial effects of Flk1 and Tal1 act to regulate cell fate choice in early development into hematopoietic, endothelial, and smooth muscle lineages.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=195986Documentos Relacionados
- Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
- SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish
- Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.
- Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
- Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
